AHCC Supplementation Effective in Supporting Immune Function to Clear Human Papillomavirus Infection: Evidence from a Double–Blind Randomized Clinical Trial
Written by Written by Tabish Mehraj, PhD, Science Writer. 3g of AHCC once daily for a 6-month duration resulted in an overall response rate of 58.8% for HPV infection clearance in women with high-risk HPV, showcasing AHCC’s ability to support the host immune system.





